Lantheus Holdings Inc (NASDAQ:LNTH) — Market Cap & Net Worth

$4.93 Billion USD · Rank #3601

Market Cap & Net Worth: Lantheus Holdings Inc (LNTH)

Lantheus Holdings Inc (NASDAQ:LNTH) has a market capitalization of $4.93 Billion ($4.93 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3601 globally and #1260 in its home market, demonstrating a 0.10% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lantheus Holdings Inc's stock price $100.54 by its total outstanding shares 66311779 (66.31 Million). Also see how large is Lantheus Holdings Inc's balance sheet for a full breakdown of the balance sheet.

Lantheus Holdings Inc Market Cap History: 2015 to 2026

Lantheus Holdings Inc's market capitalization history from 2015 to 2026. Data shows growth from $224.13 Million to $6.67 Billion (35.25% CAGR). Also see LNTH operating cash flow for how efficiently the company converts equity into cash flow.

Index Memberships

Lantheus Holdings Inc is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.66 Trillion	0.19%	#93 of 976
NASDAQ Composite IXIC	$41.69 Trillion	0.01%	#412 of 3165
S&P Midcap 400 MID	$3.41 Trillion	0.27%	#272 of 401

Weight: Lantheus Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Lantheus Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Lantheus Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check LNTH share price today for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

2.86x

Lantheus Holdings Inc's market cap is 2.86 times its annual revenue

Industry average: 0.57x Higher than industry average

Latest Price to Earnings (P/E) Ratio

18.89x

Lantheus Holdings Inc's market cap is 18.89 times its annual earnings

Industry average: 2.01x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$570.28 Million	$301.85 Million	$26.76 Million	1.89x	21.31x
2017	$1.36 Billion	$331.38 Million	$123.39 Million	4.09x	10.99x
2018	$1.04 Billion	$343.37 Million	$40.52 Million	3.02x	25.61x
2019	$1.36 Billion	$347.34 Million	$31.67 Million	3.92x	42.95x
2020	$894.55 Million	$339.41 Million	-$13.47 Million	2.64x	N/A
2021	$1.92 Billion	$425.21 Million	-$71.28 Million	4.51x	N/A
2022	$3.38 Billion	$935.06 Million	$28.07 Million	3.61x	120.40x
2023	$4.11 Billion	$1.30 Billion	$326.66 Million	3.17x	12.59x
2024	$5.93 Billion	$1.53 Billion	$312.44 Million	3.87x	18.99x
2025	$4.41 Billion	$1.54 Billion	$233.56 Million	2.86x	18.89x

Competitor Companies of LNTH by Market Capitalization

Companies near Lantheus Holdings Inc in the global market cap rankings as of September 18, 2026. Review how tangible is Lantheus Holdings Inc's equity to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Lantheus Holdings Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #519 globally with a market cap of $52.60 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #633 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #640 globally with a market cap of $43.16 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.62 Billion USD ( CN¥277.61 Billion CNY).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#519	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#633	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.00
#640	GALDERMA GROUP AG	NYSE:GALDY	$43.16 Billion	$37.02
#670	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$40.62 Billion	CN¥43.52

Lantheus Holdings Inc Historical Marketcap From 2015 to 2026

Between 2015 and today, Lantheus Holdings Inc's market cap moved from $224.13 Million to $ 6.67 Billion, with a yearly change of 35.25%.

Year	Market Cap	Change (%)
2026	$6.67 Billion	+51.07%
2025	$4.41 Billion	-25.61%
2024	$5.93 Billion	+44.29%
2023	$4.11 Billion	+21.66%
2022	$3.38 Billion	+76.39%
2021	$1.92 Billion	+114.16%
2020	$894.55 Million	-34.23%
2019	$1.36 Billion	+31.05%
2018	$1.04 Billion	-23.47%
2017	$1.36 Billion	+137.79%
2016	$570.28 Million	+154.44%
2015	$224.13 Million	--

End of Day Market Cap According to Different Sources

On Sep 17th, 2026 the market cap of Lantheus Holdings Inc was reported to be:

Source	Market Cap
Yahoo Finance	$4.93 Billion USD
MoneyControl	$4.93 Billion USD
MarketWatch	$4.93 Billion USD
marketcap.company	$4.93 Billion USD
Reuters	$4.93 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Lantheus Holdings Inc

NASDAQ:LNTH USA Drug Manufacturers - Specialty & Generic

Market Cap

$6.67 Billion

Market Cap Rank

#3601 Global

#1260 in USA

Share Price

$100.54

Change (1 day)

-0.19%

52-Week Range

$50.11 - $110.94

All Time High

$123.62